|
C11ORF73 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89764999999342E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.27719999979348E-07 |
| Normal-vs-Stage2 |
3.456300E-03 |
| Normal-vs-Stage3 |
2.722700E-03 |
| Normal-vs-Stage4 |
1.492260E-02 |
| Stage1-vs-Stage2 |
6.517400E-01 |
| Stage1-vs-Stage3 |
3.663600E-02 |
| Stage1-vs-Stage4 |
8.862300E-02 |
| Stage2-vs-Stage3 |
4.386000E-01 |
| Stage2-vs-Stage4 |
4.365000E-01 |
| Stage3-vs-Stage4 |
9.009800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.39209999999923E-06 |
| Normal-vs-AfricanAmerican |
7.811800E-01 |
| Normal-vs-Asian |
7.65590000000316E-05 |
| Caucasian-vs-AfricanAmerican |
3.399400E-03 |
| Caucasian-vs-Asian |
5.221800E-01 |
| AfricanAmerican-vs-Asian |
3.184500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.595500E-04 |
| Normal-vs-Female |
2.18100000004551E-06 |
| Male-vs-Female |
3.257400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.62590000024809E-07 |
| Normal-vs-Age(41-60Yrs) |
3.372500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.442060E-02 |
| Normal-vs-Age(81-100Yrs) |
1.654170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.927800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.761200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.818800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.951240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.732400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.864600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.844200E-01 |
| Classical-VS-Follicular |
1.174070E-02 |
| Classical-VS-Other |
8.150600E-01 |
| Classical-VS-Normal |
5.92350000050423E-07 |
| Tall-VS-Follicular |
1.689800E-01 |
| Tall-VS-Other |
8.148000E-01 |
| Tall-VS-Normal |
3.787600E-04 |
| Follicular-VS-Other |
3.004000E-01 |
| Follicular-VS-Normal |
1.699850E-02 |
| Other-VS-Normal |
2.030200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.783300E-04 |
| Normal-vs-N1 |
3.401700E-04 |
| N0-vs-N1 |
4.593600E-01 |
|
|
